Rani Therapeutics Holdings (RANI) Total Liabilities (2020 - 2025)
Historic Total Liabilities for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to $22.1 million.
- Rani Therapeutics Holdings' Total Liabilities fell 4144.84% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year decrease of 4144.84%. This contributed to the annual value of $33.1 million for FY2024, which is 205.71% up from last year.
- According to the latest figures from Q3 2025, Rani Therapeutics Holdings' Total Liabilities is $22.1 million, which was down 4144.84% from $26.1 million recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Total Liabilities registered a high of $39.0 million during Q1 2024, and its lowest value of $2.6 million during Q4 2021.
- For the 5-year period, Rani Therapeutics Holdings' Total Liabilities averaged around $24.9 million, with its median value being $31.0 million (2023).
- Per our database at Business Quant, Rani Therapeutics Holdings' Total Liabilities tumbled by 6716.42% in 2021 and then soared by 118875.0% in 2022.
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Total Liabilities stood at $2.6 million in 2021, then surged by 1188.75% to $34.0 million in 2022, then dropped by 4.56% to $32.5 million in 2023, then grew by 2.06% to $33.1 million in 2024, then crashed by 33.28% to $22.1 million in 2025.
- Its Total Liabilities was $22.1 million in Q3 2025, compared to $26.1 million in Q2 2025 and $29.5 million in Q1 2025.